Recent CLPT Stock Price | CLPT Stock Predictions | |
$5.58 | +79.21% |
$10.00 |
Recent CLPT Analyst Ratings Breakdown, Making CLPT Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 3 | 3 | 3 | 3 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the CLPT stock predictions from the analysts covering ClearPoint Neuro Inc, we have collected all of the individual CLPT stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 3 different analysts covering CLPT (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since CLPT stock predictions may vary widely, another useful metric to consider is the median CLPT stock prediction, which represents the price at which half of the analysts
made CLPT stock predictions that were higher and half made CLPT stock predictions that were lower. This makes for a different take on the CLPT stock predictions out there, as compared to average or mean.
And that median across all the individual CLPT stock predictions was: $10.0 as of 2024-04-17.
The very highest of the CLPT stock predictions for one year price target was $11.0, while the very lowest of the CLPT stock predictions in the analyst group was
$9.0 (with a standard deviation of $1.0). Get the latest Zacks research report on CLPT — FREE
Find out: CLPT next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
FANG Stock Predictions
HAL Stock Predictions
PCTY Stock Predictions
ESQ Stock Predictions
XENE Stock Predictions
SONN Stock Predictions
CLSK Stock Predictions
SRE Stock Predictions
PEB Stock Predictions
|
|
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |